Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.
TipRanks on MSN
Algernon Health Secures CAD $210,000 in Private Placement to Boost Alzheimer’s Program
Algernon Pharmaceuticals ( ($TSE:AGN) ) just unveiled an update. Algernon Health Inc. announced the closing of the second tranche of its ...
As Alzheimer’s Awareness Month comes to an end, Florida State University researchers are continuing efforts to better ...
Researchers at Brain Chemistry Labs, a state-of-the-art biology laboratory in Jackson, are studying the brains of dolphins in ...
Doug Hano has struggled for years to find reliable care for his wife, Kirsten, who has early-onset Alzheimer’s disease.
A new study from the University of California San Diego may have found a helpful clue. The researchers discovered that an enzyme in the blood called PHGDH could be used to detect Alzheimer’s early.
Q: I'm feeling a little fuzzy-brained and am debating whether to get tested for Alzheimer's. Do you think it's a good idea? -- Cassie R., Knoxville, Tennessee ...
Share on PinterestNovo Nordisk has announced the cessation of the Evoke trials, looking at whether GLP-1 drugs could help ...
The share price of Danish pharmaceutical giant Novo Nordisk ( NVO +1.31%) hit a four-year low Monday, falling below $44 a ...
Having the highest levels of physical activity in midlife and late life was associated with a 41% and 45% lower risk of ...
Administering an amino acid used to treat high blood pressure also appears to reverse signs of dementia in mice.
For Johnston County Registrar of Deeds Craig Olive and his blended family, Alzheimer’s disease is personal. He and his kin have seen the disease ravage parents, siblings, grandparents, aunts and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results